Building an Effective Drug Franchise:
A Transatlantic Perspective
April 23, 2019 | Boston, MA
It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your innovation. In this networking seminar, we will share real-life case studies and provide practical advice on maximizing the scope and duration of patent protection for your drug or clinical candidate in both US and European markets.
Join us on April 23rd to hear IP attorneys from Wolf Greenfield (US) and Mewburn Ellis (Europe) compare and contrast the patent strategies available to build a robust patent portfolio.
Panelists
Sarah Kostiuk-Smith, European Patent Attorney, Chemistry Team, Mewburn Ellis
Hunter Baker, Chair, Pharmaceutical Group, Wolf Greenfield
Emily Hayes, European Patent Attorney, Life Sciences Team, Mewburn Ellis
Dan Young, Shareholder, Biotechnology Group, Wolf Greenfield
